919.882.7145
iwigley@wyrick.com
Isabel is a member of the firm’s Corporate practice group. She focuses primarily on mergers and acquisitions, representing corporate and private equity clients in M&A transactions on both the buy-side and sell-side in a wide range of industries.
Prior to joining the firm in 2024, Isabel worked at an AmLaw 100 firm in Washington, D.C., where she represented Fortune 500 companies in merger investigations by the Federal Trade Commission and the U.S. Department of Justice Antitrust Division.
Isabel received her J.D. from Georgetown University Law Center, where she served as an Executive Annual Survey Editor of the American Criminal Law Review. Prior to attending law school, Isabel earned her B.A. in English Literature, with honors, from the University of North Carolina at Chapel Hill.
Isabel is licensed to practice in North Carolina and the District of Columbia.
- American Bar Association
- North Carolina Bar Association
- North Carolina State Bar
- District of Columbia Bar
- Wake County Bar Association
- Represented Apiture, a provider of digital banking solutions to U.S. financial institutions, in its sale to Computer Services, Inc., a leading provider of end-to-end financial software and technology.
- Represented television broadcasting company in the acquisition, via asset purchase, of five broadcast television stations.
- Represented leading healthcare philanthropy consulting group in its acquisition by a private equity firm.
- Represented Globus Medical (NYSE: GMED) in its $250 million acquisition of Nevro Corp, a global medical device company delivering comprehensive solutions for the treatment of chronic pain.
- Represented medical device company in the sale of its newborn screening laboratory solution to a biotechnology company specializing in genetic testing and diagnostics.
- Represented global life sciences company in the transfer of its pharmaceutical sample and fulfilment services business to a large U.S. supplier of end-to-end pharmaceutical healthcare marketing services and solutions.
- Represented dental industry procure-to-pay platform company in its sale to a strategic acquiror.
- Represented a leading provider of regulated material management services in a strategic growth investment from a leading healthcare-focused private equity firm.
- Perjury, 60-3 Am. Crim. L. Rev 1127 (2023)
- False Statements and False Claims, 60-3 Am. Crim. L. Rev. 781 (2023)
